logo

For the Inventor, By the Inventor

Kendall Park, NJ, United States of America

Actinobac Biomed, Inc.


USPTO Granted Patents = 8



Forward Citations = 8

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Scott Kachlany (8 out of 15 patents)

silverMedal Benjamin Belinka (5 out of 5 patents)

bronzeMedal Benjamin A Belinka, Jr (3 out of 14 patents)

4.  Scott C Kachlany (0 patent)


8 patents:

1. 11612636 - Method of treating autoimmune inflammatory crohn's disease (2023-03-28),
2. 10993989 - Treatment and diagnosis of inflammatory disorders and HIV (2021-05-04),
3. 10603354 - Treatment and diagnosis of inflammatory disorders and HIV (2020-03-31),
4. 10226506 - Treatment and diagnosis of inflammatory disorders and HIV (2019-03-12),
5. 9950030 - Treatment and diagnosis of ocular disease (2018-04-24),
6. 9849156 - Treatment and diagnosis of inflammatory disorders and HIV (2017-12-26),
7. 9724384 - Methods to treat inflammation of the lung (2017-08-08),
8. 9352017 - Combination therapy with leukotoxin (2016-05-31),
Actinobac Biomed, Inc. is a biotechnology company focused on developing novel therapies for infectious diseases. Our team of researchers specialize in harnessing the power of actinobacteria to create innovative treatments that address unmet medical needs. With a strong commitment to scientific excellence and patient care, we strive to bring groundbreaking solutions to the market.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#1 in Kendall Park, NJ

#1,332 in New Jersey

#34,852 in US

...
Kendall Park, NJ, United States of America

Actinobac Biomed, Inc.

Forward Citations = 8

4 inventors:

goldMedal Scott Kachlany (8 out of 15 patents)

silverMedal Benjamin Belinka (5 out of 5 patents)

bronzeMedal Benjamin A Belinka, Jr (3 out of 14 patents)

4.  Scott C Kachlany (0 patent)

Please report any incorrect information to support@idiyas.com
Loading…